AUROBINDO LANNETT DEAL
US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisitionThe U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...18 Jun, 2026, 10.53 PM IST
Aurobindo Pharma closing in on $5.5b Zentiva buyoutLargest Indian pharma M&A in final lap; PE firm GTCR only other contender. A portfolio company of Advent International, Zentiva will signif...20 Aug, 2025, 06.19 AM IST
Load More